Atlantic Private Wealth’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$287 Hold
30
– – ﹤0.01% 293
2026
Q2
$238 Hold
30
– – ﹤0.01% 296
2026
Q1
$174 Hold
30
– – ﹤0.01% 311
2025
Q4
$236 Buy
+30
New +$236 ﹤0.01% 380

Other funds holding XERS

Atlantic Private Wealth's XERS Position: Q3 2026 in Review

Atlantic Private Wealth held its Xeris Biopharma Holdings (XERS) position steady in Q3 2026 at 30 shares worth $287. The position accounts for ﹤0.01% of the portfolio, ranked #293.

Atlantic Private Wealth first reported a position in XERS in Q4 2025 and has held it in 4 quarters since. 182 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • Atlantic Private Wealth held 30 shares of Xeris Biopharma Holdings worth $287 as of Q3 2026.
  • Atlantic Private Wealth left its Xeris Biopharma Holdings share count unchanged in Q3 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Atlantic Private Wealth's portfolio in Q3 2026, its #293 holding.
  • Atlantic Private Wealth first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 4 quarters since.
  • 182 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Atlantic Private Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.